Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica
A Escribá(Hospital Universitario 12 De Octubre), Manuel Praga(Universidad Complutense de Madrid), Beatriz Domínguez‐Gil(Universidad de Zaragoza), Enrique Morales(Universidad Complutense de Madrid), Enriqueta Albízua(Hospital Universitario HM Madrid), M. Teresa Agulló-Ortuño(University of Castilla-La Mancha), Juan Carlos Herrero(Hospital Universitario Severo Ochoa), Agustín Carreño(Hospital Universitario 12 De Octubre)
Cited by 22
Related Papers
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
|Kidney International|2014|506
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
|The Lancet Diabetes & Endocrinology|2019|383
Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy
|Kidney International|2000|354
Donation after circulatory death today: an updated overview of the European landscape
|Transplant International|2019|317